D1 Capital Partners has led a series E round for Outset Medical, pushing the OSU dialysis device spinout’s overall funding to more than $430m.
Outset Medical, a US-based mobile dialysis machine developer based on Oregon State University research, has secured $125m in a series E round led by investment firm D1 Capital Partners.
Financial services and investment group Fidelity Management and Research also took part in the round, as did investment management firm Partner Fund Management, hedge fund sponsor Perceptive Advisors and funds advised by asset manager T. Rowe Price Associates.
Founded as Home Dialysis Plus in 2003, Outset has created a…
